İNANÇ, G. N. Et Al. 2023. Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib. Journal of Clinical Rheumatology , vol.29, no.8 , 365-369.

İNANÇ, G. N., Abacar, K. Y., ÖZTÜRK, M. A., TUFAN, A., Karadeniz, H., SARI, İ., ... CAN, G.(2023). Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib. Journal of Clinical Rheumatology , vol.29, no.8, 365-369.

İNANÇ, GÜZİDE Et Al. "Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib," Journal of Clinical Rheumatology , vol.29, no.8, 365-369, 2023

İNANÇ, GÜZİDE N. Et Al. "Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib." Journal of Clinical Rheumatology , vol.29, no.8, pp.365-369, 2023

İNANÇ, G. N. Et Al. (2023) . "Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib." Journal of Clinical Rheumatology , vol.29, no.8, pp.365-369.

@article{article, author={GÜZİDE NEVSUN İNANÇ Et Al. }, title={Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib}, journal={Journal of Clinical Rheumatology}, year=2023, pages={365-369} }